CareFusion Corp

CareFusion — Q3 2011 Earnings Presentation

16 slides from CareFusion's earnings presentation, May 5, 2011

  1. Slide 1: Q3 and 9-Months Fiscal 2011 Investor/Analyst Call

    Exhibit 99.2 Q3 and 9-Months Fiscal 2011 Investor/Analyst Call May 5, 2011 © 2011 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  2. Slide 2: Forward-Looking Statements, GAAP Reconciliation and ISP Divestiture

    Forward-Looking Statements, GAAP Reconciliation and ISP Divestiture “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future

  3. Slide 3: Today's Speakers

    Today’s Speakers • Kieran Gallahue, Chairman and Chief Executive Officer • Jim Hinrichs, Chief Financial Officer © 2011 CareFusion Corporation or one of its subsidiaries. All rights reserved. 3

  4. Slide 4: Q3 and 9-Months Fiscal 2011 Results

    Q3 and 9-Months Fiscal 2011 Results © 2011 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  5. Slide 5: Q3 Fiscal 2011 Year-Over-Year Quarterly Review

    Q3 Fiscal 2011 Year-Over-Year Quarterly Review GAAP Adjusted 1 1 $M % Change $M % Change Revenue $867 4% $867 4% 2 Operating Expenses $301 (8)% $292 (6)% 2 Operating Income $146 70% $155 49% Income from Continuing 2 $86 762% $94 77% Operations Diluted EPS from Continuing $0.38 733% $0.42 75% Operati

  6. Slide 6: Q3 Fiscal 2011 Year-Over-Year Quarterly Segment Review

    Q3 Fiscal 2011 Year-Over-Year Quarterly Segment Review GAAP Adjusted 1 1 Critical Care Technologies (CCT) $M % Change $M % Change Revenues $661 5% $661 5% 2 Segment Profit $115 49% $129 43% Medical Technologies and Services 1 1 $M % Change $M % Change (MTS) Revenues $206 (1)% $206 (1)% 2 Segment Pro

  7. Slide 7: 9-Months Fiscal 2011 Review

    9-Months Fiscal 2011 Review GAAP Adjusted 1 1 $M % Change $M % Change Revenue $2,564 1% $2,564 1% 2 Operating Expenses $958 -- $882 (2)% 2 Operating Income $347 7% $423 13% Income from Continuing $195 76% $253 14% Operations 2 Diluted EPS from Continuing $0.87 74% $1.13 14% Operations 2 1 % Change o

  8. Slide 8: 9-Months Fiscal 2011 Segment Review

    9-Months Fiscal 2011 Segment Review GAAP Adjusted 1 1 Critical Care Technologies (CCT) $M % Change $M % Change Revenues $1,962 2% $1,962 2% 2 Segment Profit $298 3% $357 9% Medical Technologies and Services 1 1 $M % Change $M % Change (MTS) Revenues $602 (2)% $602 (2)% 2 Segment Profit $34 -- $66 35

  9. Slide 9: Fiscal 2011 Guidance

    Fiscal 2011 Guidance © 2011 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  10. Slide 10: Fiscal 2011 Financial Guidance May 5, 2011

    Fiscal 2011 Financial Guidance May 5, 2011 1,2 $ in millions Previous FY11 Outlook Updated FY11 Outlook Low single digit growth over FY10 Low single digit growth over FY10 Total Revenue revenue of $3.5B on a reported and revenue of $3.5B on a reported and 3 constant currency basis constant currency

  11. Slide 11: Updated Fiscal 2011 Revenue and Adjusted EPS Guidance and Assumptions

    Updated Fiscal 2011 Revenue and Adjusted EPS Guidance and Assumptions Guidance • Revenue growth of low single digits • Adjusted diluted EPS from continuing operations of $1.60 to $1.65 Assumptions • Hospital capital spending grows low to mid single digits; customers continue prioritizing spending •

  12. Slide 12: Updated Fiscal 2011 CCT Segment-related Assumptions vs. Fiscal 2010 Results

    Updated Fiscal 2011 CCT Segment-related Assumptions vs. Fiscal 2010 Results • Segment revenue grows on a percentage basis by low to mid single digits Infusion: Revenues grow on a percentage basis in the low teens due to Medegen acquisition and from incremental market share gains in 2H FY11 following

  13. Slide 13: Updated Fiscal 2011 MTS Segment-related Assumptions vs. Fiscal 2010 Results

    Updated Fiscal 2011 MTS Segment-related Assumptions vs. Fiscal 2010 Results • Segment revenue essentially flat ChloraPrep ® business: Grows double digits based on successful execution of growth strategy both domestically and internationally International Surgical Products divested: Closed in April 2

  14. Slide 14: Q&A

    Q&A © 2011 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  15. Slide 15: Q3 Fiscal 2011 Non-GAAP Reconciliations

    Q3 Fiscal 2011 Non-GAAP Reconciliations Q3 FY11 Nonrecurring Q3 FY11 $ in millions GAAP Items Adjusted 1 Operating Expenses $301 $(9) $292 1 Operating Income $146 $9 $155 Income From Continuing 1 $86 $8 $94 Operations Diluted EPS From Continuing 1 $0.38 $0.03 $0.42 Operations Critical Care Technolog

  16. Slide 16: 9-Months Fiscal 2011 Non-GAAP Reconciliations

    9-Months Fiscal 2011 Non-GAAP Reconciliations 9-Months FY11 Nonrecurring 9-Months FY11 $ in millions GAAP Items Adjusted 1 Operating Expenses $958 $(76) $882 1 Operating Income $347 $76 $423 Income From Continuing 1 $195 $58 $253 Operations Diluted EPS From Continuing 1 $0.87 $0.26 $1.13 Operations

CareFusion — Q3 2011 Earnings Presentation on 6ix